Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Tiotropium Bromide in Cystic Fibrosis
NCT02172534Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2006
- Primary completion
- Sep 2008
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of tiotropium in cystic fibrosis (CF) (6 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Changes from baseline in physical examination at Day 28, Changes from baseline in blood pressure at Day 28 and 6 more. Started Sep 2006; status: completed.
02
Drugs
tiotropium
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02172534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02172534.